FCF1 Inhibitors
FCF1 inhibitors are a class of chemical compounds that specifically target and modulate the function of FCF1, a factor critical for the processing and maturation of ribosomal RNA (rRNA). FCF1, also known as FACT complex subunit, is integral in ribosome biogenesis, where it assists in the proper assembly of ribonucleoprotein particles. Ribosome biogenesis is essential for protein synthesis in cells, and FCF1 plays a key role in this highly regulated and complex process. FCF1 is involved in cleaving pre-rRNA at specific sites, ensuring that mature rRNA is properly processed and assembled into functional ribosomes. Inhibitors targeting FCF1 interfere with this process, disrupting the formation of ribosomes by blocking the necessary cleavages and processing events that lead to functional rRNA. This inhibition ultimately affects cellular functions that depend on protein synthesis, particularly in cells with high rates of ribosome production.
Chemically, FCF1 inhibitors vary in structure but typically share a common ability to bind to FCF1 or its associated complexes, preventing their normal enzymatic activity. These inhibitors often possess characteristics that enable them to interact with key residues in the catalytic or binding domains of FCF1, halting its function. Structural studies have revealed that FCF1 inhibitors can exhibit selectivity for the FCF1 protein, reducing off-target effects on other cellular pathways. The mode of action of these inhibitors tends to involve allosteric modulation or direct competition with the natural substrates of FCF1. Research into the detailed mechanisms of FCF1 inhibition has provided insights into how disrupting rRNA processing can affect cellular processes at the molecular level. This makes FCF1 inhibitors valuable tools for studying ribosome biogenesis and its regulation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation in the endoplasmic reticulum. By blocking the glycosylation of nascent proteins, tunicamycin can disrupt proper folding and stability of FCF1, as glycosylation might be crucial for its function or stability. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of GDP to GTP on ADP-ribosylation factors, causing disassembly of the Golgi apparatus. Impaired protein trafficking can lead to a reduced functional translocation of FCF1, thereby indirectly inhibiting its activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thus potentially reducing the amount of FCF1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Known to form a complex with FKBP12 that binds to and inhibits mTOR, which is a key regulator of protein synthesis and cell growth. Inhibition of mTOR may decrease the synthesis of proteins including FCF1. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis. This can lead to reduced levels of many proteins, including FCF1, by preventing their full translation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A peptide aldehyde that inhibits proteasomes, leading to an accumulation of polyubiquitinated proteins and potential interference with protein turnover. The accumulation of misfolded or damaged proteins may indirectly affect the stability and function of FCF1. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A cyclopeptide that inhibits RNA polymerase II, thereby blocking mRNA synthesis. This inhibition can lead to decreased synthesis of proteins, including FCF1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Intercalates into DNA and prevents RNA synthesis by inhibiting RNA polymerase. By preventing mRNA production, it can indirectly lead to decreased levels of FCF1. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A 4-aminoquinoline compound that raises the pH in intracellular vesicles, impairing protein degradation in lysosomes. The resulting alteration in cellular autophagy and degradation pathways can affect the turnover and function of FCF1. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
An alkylating agent that crosslinks DNA, leading to the inhibition of DNA replication and transcription. The resulting stress on the cell can lead to a decrease in the synthesis of proteins such as FCF1. | ||||||